Milestone Pharmaceuticals Inc. — Director's Dealing 2022

Feb 17, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Milestone Pharmaceuticals Inc. (MIST)
CIK: 0001408443
Period of Report: 2022-02-15

Reporting Person: Bharucha David (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-02-15	Employee Stock Option (right to buy)	$6.47	A	330000	Acquired	2032-02-15	Common Shares (330000)	Direct

Footnotes

F1: One-fourth (1/4th) of the shares subject to the option vest on February 15, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.